Trial Information

Summary: Multiple Sclerosis Study

Participants Needed

For a new clinical research study in Multiple Sclerosis at Northwest NeuroSpecialists

• Individuals with MS who have experienced 2 or more attacks in the past 2 years or 1 or more attacks in the past 6 months
• Ages 18-65
• Not currently taking disease modifying therapy
  (including beta interferons or glatiramer acetate)

This clinical research study will test a new experimental therapy that is designed to suppress the inflammation that causes damage to nerve fibers in patients with MS. The study drug is delivered by subcutaneous injection administered by a research nurse once a week for the first month and then once a month for 4 months. Participants will continue to be seen for 9 more months. 1 in 5 subjects will receive an injection with no active drug.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:13 AM